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innate immune responses, such as those from naturalCroatia
killer (NK) cells that demonstrate enhanced killing of
targets that lack MHC class I expression, as predicted
by the “missing-self” hypothesis (Ljunggren and Karre,Summary
1990). Countering this host response, MCMV contains
an ORF (m144) that appears to inhibit NK cells appar-As innate immune system components, natural killer
ently through an as yet undefined inhibitory NK cell re-(NK) cells respond rapidly to infections and effectively
ceptor, analogous to human CMV ORFs that encodecontrol replication of pathogens, including murine cy-
ligands for NK cell inhibitory receptors (Farrell et al.,tomegalovirus (MCMV), a double-stranded DNA-her-
1997; Reyburn et al., 1997; Tortorella et al., 2000). Thus,pesvirus. In the absence of NK cell control, MCMV
the complex interplay between the virus and the hostinfection results in early mortality due to uncontrolled
usually reflects long-standing co-evolution of the virusviral replication. However, here we show that even in
with the host immune system rather than during thethe face of initial NK cell control, there is late recrudes-
context of an ongoing viral infection.cence of disease and mortality in immunodeficient
Studies of MCMV infection have also highlighted themice due to the outgrowth of MCMV mutants that
intricate relationship between the adaptive and innateescape recognition by innate NK cells. These data
arms of the immune system. There is clearly a role for
suggest that viral infections in certain clinical settings
the protective effects of acquired specific immune re-
also may be due to viral escape from innate immunity.
sponses, primarily from CD8 CTLs (Reddehase et al.,
1987). However, mice with deficiencies in innate immune
Introduction function succumb to MCMV infection before acquired
immunity becomes manifest (reviewed in Biron, 1999).
The innate immune system effectively controls patho- A major component of innate immunity, the NK cell,
gens, such as viruses, during the initial phases of the provides vital host innate immune defense against
host immune response (Janeway, 2001). This control is MCMV by killing infected cells and producing cytokines
crucial to host survival, since adaptive specific immunity such as IFN- (Biron et al., 1999; Bukowski et al., 1983).
becomes manifest only after a lag period of a week or Specific NK cell control of MCMV is genetically deter-
more during which there is clonal selection and expan- mined by Cmv1, an autosomal dominant locus, outside
sion of antigen-specific T and B cell clones. In the ab- the MHC, that renders C57BL/6 (B6) mice resistant to
sence of innate immune components, pathogen replica- MCMV whereas BALB/c mice are susceptible (Scalzo et
tion may be so rapid that infection overwhelms the host, al., 1990). Cmv1 encodes the Ly49H activation receptor
resulting in death within the first few days of disease expressed on about 50% of NK cells in B6 mice (Brown
(Brown et al., 2001; Salazar-Mather et al., 2002). On the et al., 2001; Lee et al., 2001). Ly49H specifically recog-
other hand, the absence of adaptive immunity leads nizes the MCMV-encoded ORF product m157, a glyco-
to susceptibility to infection and inability to clear the phosphatidylinositol (GPI)-anchored protein, on virally
pathogens as illustrated by immunocompromised hu- infected cells, and triggers NK cell-mediated cytotoxic-
ity and cytokine production (Arase et al., 2002; Smith et
al., 2002). Interestingly, mice with intact adaptive im-*Correspondence: yokoyama@im.wustl.edu
mune systems but genetically lacking Ly49h, such as5 Present address: Department of Pathology, Harvard Medical
School, Boston, Massachusetts 02115. BALB/c (Cmv1s allele), can survive infection with low
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doses of MCMV but are susceptible to challenges with
higher inoculi of MCMV as evidenced by markedly ele-
vated splenic viral titers, already evident by day 3 post-
infection (p.i.), and decreased survival with deaths oc-
curring early around day 6–7 p.i. (Scalzo et al., 1990). By
contrast, Ly49H (Cmv1r) strains, such as B6 or BALB/c
mice reconstituted with Ly49h by transgenesis, have low
viral titers and survive infection with similar inoculums of
MCMV (Brown et al., 2001; Lee et al., 2001, 2003; Scalzo
et al., 1990). Taken together with immunological analysis
(Brown et al., 2001; Daniels et al., 2001), these data
demonstrate that the Ly49H NK cell activation receptor
mediates acute innate immune control of MCMV and
is responsible for the increased resistance of B6 mice
to MCMV.
In the current studies, however, we demonstrate that
innate NK cell control of MCMV infection in mice on the
B6 background is inadequate for long-term survival if
the host lacks adaptive immunity. After a single inocu-
lum, there is recrudescence of disease due to MCMV
mutants that escape NK cell control rather than to re-
emergence of the original virus. These studies have sig-
nificant implications for the clinical setting as the data
suggest that pathogens that cause severe disease in
immunocompromised patients may represent mutants
escaping innate immunity.
Results
Late Lethality in MCMV-Infected
Immunodeficient Mice
Despite acute innate immune control, B6 mice lacking
an adaptive immune system, i.e., immunodeficient B6-
SCID or B6-RAG1/ mice, experienced late deaths oc-
curring 3 to 5 weeks p.i. (Figure 1A). Similar results were
observed in several other cohorts of B6-RAG1/ and
B6-SCID mice infected with doses of MCMV as low as
2  104 pfu, inoculi significantly less than the LD50 of
MCMV in wt B6 mice (2.5  105 pfu, data not shown).
These results correlate well with a previous report of
late deaths observed in another immunodeficient mouse
(B6.RAG2/) infected with MCMV (Riera et al., 2000)
and contrast sharply with the much earlier deaths (day
6–7 p.i.) in mice on a genetically susceptible background
such as BALB/c (including CB.17-SCID), or in otherwise
resistant B6 mice with genetic or induced defects in
innate immunity or NK cells (Brown et al., 2001; Bukow-
Figure 1. Survival and Splenic Titers in B6-RAG1/ and B6-SCID
ski et al., 1983; Salazar-Mather et al., 2002; Scalzo etMice during MCMV Infection
al., 1990).(A) Survival curve for 30 B6-RAG1/ mice infected i.p. with 2.5 
Whereas wt B6 mice were able to control MCMV infec-104 pfu wt MCMV (Smith strain) per mouse (solid line). At this and
tion with undetectable splenic titers at day 28 p.i., surviv-higher doses, all wt B6 mice survive (Brown et al., 2001) as illustrated
by the survival curve of six B6 mice infected i.p. with 5  104 pfu ing B6-SCID mice consistently had higher titers at day
MCMV (Smith strain) per mouse (dotted line) from a separate experi- 28 than at day 3 p.i. (Figure 1B; data not shown). The
ment shown for comparison. lower initial (day 3 p.i.) titers in B6-SCID as compared
(B) Splenic titers at day 3 (d3) p.i. and day 28 (d28) p.i. in groups of
to B6 spleens may be partially explained by the propor-four to five wt B6 or B6-SCID mice infected with 2 104 pfu/mouse.
tionally greater fraction of NK cells in the B6-SCID spleenThe horizontal dashed line represents the level of detection of the
(25% versus 2.5% in wt mice). The splenic titers in B6-assay. For mice with titers below the level of detection, the minimum
number of detectable pfus was used to determine the mean. The SCID mice decreased further from day 3 to day 7 p.i.
differences in splenic titers at d3 and d28 were statistically signifi-
cant in both B6 (p  0.0007) and B6-SCID mice (p  0.007).
(C) Splenic titers at days 3, 7, 14, and 28 p.i. in groups of four to
five C57BL/6-SCID mice infected with 2  104 pfu/mouse. Mean cated. Titers may have been significantly higher in mice that died
viral titers for each group are depicted as horizontal bars. (In [B] prior to d28, and are therefore likely to be an underestimate of viral
and [C], viral titers were determined in mice surviving at days indi- titers associated with death itself.)
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However, the titers then rebounded to much higher lev- Lack of Ly49H NK Cell Stimulation
by SCID-MCMV Isolatesels (Figure 1C), indicating that the immunodeficient mice
Instead of re-emergence of the original virus, the datawere initially able to control the MCMV infection but at
suggested that MCMV isolated during recrudescencelater time points (day 28 p.i.) the virus escaped this
of infection in B6-SCID mice were mutants that hadcontrol (Figure 1A and 1C).
escaped from NK cell control because the SCID-MCMVThe recrudescence of disease in immunodeficient
isolates were unrestrained when reintroduced into im-mice but not in wt mice (Figure 1) suggested that the re-
munocompetent wt B6 mice. This phenotype (mortality,emergence of MCMV is due to the absence of adaptive
time to death, elevated viral titers) resembled that ofimmune cells. Indeed, previous studies have docu-
infections with wt MCMV in NK cell depleted or Ly49H-mented the role of adaptive immunity in controlling
deficient mice (Brown et al., 2001; Bukowski et al., 1983;MCMV infections in immunocompetent mice (Redde-
Scalzo et al., 1990). Based on this evidence, we hypothe-hase, 2002). The transfer of splenocytes from MCMV-
sized that the SCID-MCMV isolates had escaped NKchallenged immunocompetent mice into MCMV-infected
cell control by specifically affecting Ly49H stimulationB6-SCID mice completely prevented elevation of late
of NK cells. To evaluate this possibility, we took advan-splenic viral titers (data not shown). Therefore, although
tage of previous observations (Smith et al., 2002) reca-Ly49HNK cells provide effective early control of MCMV
pitulated here (Figure 3A) that in vitro co-incubation of(Figure 1, Brown et al., 2001), an adaptive immune re-
splenocytes with wt MCMV-infected IC-21 macro-sponse is necessary to prevent the re-emergence of
phages results in downregulation of Ly49H expressionMCMV late during infection, indicating that early innate
and enhanced selective stimulation of IFN- productionimmunity alone is insufficient for long-term control of
from Ly49H NK cells due to direct activation throughMCMV infection.
Ly49H itself. In contrast, co-incubation of C57BL/
6-RAG1/ splenocytes with IC-21 macrophages in-
fected with SCID-MCMV isolates did not stimulate theseMCMV Isolates from Immunodeficient Mice
responses in Ly49H NK cells (Figure 3A). In addition,The re-emergence of MCMV late during infection in B6-
in vivo analysis of B6 mice infected with wt MCMV re-SCID mice could represent the reactivation from latency
vealed selective expansion of the Ly49H NK cells asof MCMV representing the original inoculum, the selec-
indicated by the increased percentage of splenic
tion of MCMV escape mutants, or immunosuppression
Ly49HNK cells following infection (Figure 3B). Previous
of innate immunity through constant stimulation from
studies have shown that this expansion is due to selec-
persistent occult infection, analogous to T cell exhaus-
tive Ly49H stimulation and proliferation of Ly49H NK
tion in viral infections (Zinkernagel et al., 1999). To test cells (Dokun et al., 2001). On the contrary, when B6
these hypotheses, we isolated plaque-purified MCMV mice were infected with similar inoculi of SCID-MCMV
from spleen homogenates of surviving B6-SCID mice at isolates, there was no shift in the proportion of NK cells
day 28 p.i. We then used these new isolates, termed that were Ly49H. Similar results were observed when
SCID-MCMV, to infect B6-SCID mice. Infection with a B6 mice were infected with lower doses of MCMV (data
SCID-MCMV isolate (A1.10) resulted in marked mortality not shown). Interestingly, early (36 hours p.i.) Ly49H-
in B6-SCID mice by day 7, indicating ineffective innate independent “non-specific” in vivo stimulation of NK
control (Figure 2A). Similarly there was 70%–100% mor- cells (proliferation and IFN- production) (Dokun et al.,
tality in infections with 3 separate SCID-MCMV isolates 2001) during infection with SCID-MCMV isolates was
in wt B6 mice compared to 100% survival at 28 days not attenuated, as compared to infection with wt MCMV
with wt virus infection (Figure 2B). Similar results were (data not shown). Taken together, these data demon-
observed in a second independent experiment (data not strate that the SCID-MCMV isolates manifest selective
shown). The LD50 of SCID-MCMV isolate A1.10 was 3  abnormalities in the specific in vitro and in vivo stimula-
104 pfu, about one-tenth the LD50 of wt MCMV, passaged tion of Ly49H NK cells.
an equivalent number of times in vivo (data not shown).
Infection with these isolates in B6 mice resulted in signif- m157 Mutations in SCID-MCMV Isolates
icantly higher day 3 splenic titers than infection with Specific stimulation of Ly49H NK cells requires Ly49H
the same dose of wt MCMV (Figure 2C). More modest recognition of MCMV-encoded m157 (Arase et al., 2002;
differences (3- to 14-fold) were seen between day 3 Smith et al., 2002). We therefore hypothesized that there
hepatic titers in mice infected with wt MCMV and SCID- may be mutations in m157 in the SCID-MCMV isolates
MCMV isolates (Figure 2D) consistent with previous ob- facilitating escape from innate immune control. Indeed,
servations that the Cmv1r MCMV resistance locus the vast majority of splenic SCID-MCMV isolates in
(Ly49h) is characterized primarily by decreased splenic eleven mice from three separate experiments were
titers and increased survival with significantly less effect found to have mutations in m157 (Table 1, each experi-
on hepatic titers (Brown et al., 2001). These data strongly ment designated by a different letter, A, B, or C). In
suggest that the elevated titers observed late in the sequencing the 993 nucleotides (nt) comprising the
infection of SCID mice (Figure 1C) result from changes m157 ORF from 64 independent splenic isolates, we
in the virus and not from exhaustion of host innate immu- found mutations in 61 (95%). The most common muta-
nity because the phenotype of uncontrolled viral replica- tion was a 13 nt deletion in the predicted membrane
tion and death could be recapitulated with the SCID- proximal hydrophobic tail of m157 that would preclude
MCMV isolates early in the course of infection when GPI linkage. Other deletions or substitutions change the
frame or result in premature stop codons. Indeed, 56 ofB6-SCID and wt B6 mice are normally resistant.
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Figure 2. Increased Mortality and Splenic
and Hepatic Titers in B6-SCID and B6 Mice
Infected with SCID-MCMV Isolates
(A) Survival curves of groups of 6 B6-SCID
mice infected i.p. with (5  104 pfu/mouse)
wt MCMV (squares) or SCID-MCMV A1.10
isolate (triangles).
(B) Survival curves of groups of seven B6
mice infected i.p. (6  104 pfu/mouse) with
wt MCMV (squares) or SCID-MCMV isolates
including A1.05 (circles) and A1.10 (triangles),
both of which have a 3 thirteen nucleotide
deletion, and A1.04 (diamonds), which has a
5 deletion. Results are representative of two
independent experiments. A wt MCMV stock
that had been passed an additional time
through BALB/c mice so that it had the same
number of in vivo passages through BALB/c
mice as the SCID-MCMV isolates had an
identical LD50 as the parental wt stock (2.5 
105 PFU), and a group of B6 mice infected
with this wt MCMV stock (6 104 pfu/mouse)
all survived (data not shown) similar to mice
infected with the parental wt stock.
(C) Splenic titers at day 3 p.i. in groups of four
B6 mice infected with 2  104 pfu/mouse of either wt MCMV or two SCID-MCMV isolates (A1.05 and A1.10). The d3 splenic titers in B6 mice
infected with the SCID-MCMV isolates were statistically distinct from titers in mice infected with wt MCMV (p  0.0000001 for A1.05 and p 
0.00000002 for A1.10).
(D) Hepatic titers at day 3 p.i. in the same groups of four B6 mice infected with 2  104 pfu/mouse of either wt MCMV or two SCID-MCMV
isolates (A1.05 and A1.10). The differences in hepatic titers in B6 mice infected with wt MCMV or SCID-MCMV isolates were statistically
significant (p  0.03 for A1.05 and p  0.0003 for A1.10).
the 61 mutations identified are predicted to disrupt the elevated splenic titers on day 28 were again observed
(data not shown). Sequencing of m157 in 28 splenicexpression and retention of the full-length m157 prod-
uct. In striking contrast, sequencing of two adjacent isolates from four B6-SCID mice revealed mutations in
all the isolates (Table 3). Substitutions or deletions re-ORFs that belong to the same m145 family in the MCMV
genome as m157 revealed no mutations in m158 (1071 sulting in premature stop codons in m157 were found
in 25 of 28 mutated isolates. Interestingly, each mousent) in 13 isolates or in m159 (1197 nt) in 12 isolates all
of which contained m157 mutations. While there may had an independent dominant m157 mutation that was
not seen in the other mice. These results strongly sup-be additional mutations in other MCMV ORFs that were
not detected in our analysis of these three genes, these port the hypothesis that MCMV is mutating during the
course of infection in the mice and being selected underresults clearly demonstrate that m157 mutants were se-
lected during MCMV infection in B6-SCID mice. pressure from NK cells.
Whereas other mutations may also be present in theWe also found elevated hepatic titers on day 28 p.i.
in B6-SCID mice (data not shown). Sequencing demon- SCID-MCMV isolates and contribute to their increased
virulence, deliberate mutation of m157 (	m157) recapit-strated m157 mutations in 19 out of 20 hepatic SCID-
MCMV isolates (Table 2) closely correlating with the ulated the SCID-MCMV phenotype of elevated viral titers
(Figure 3C) and inability to activate Ly49H NK cellsm157 mutations found in splenic SCID-MCMV isolates
from the same mice (Table 1). These results demonstrate (Figure 3A). The phenotype of 	m157 was restored to
that of wt MCMV by intentional re-introduction of m157.that mutant MCMV is disseminated and that the spleen
is not a privileged site to observe m157 mutations. Furthermore, studies of 	m157 support the thesis that
m157 alone is involved in the genetic resistance of B6The experiments presented in Tables 1 and 2 were
done with salivary gland-passaged MCMV stocks. No mice to MCMV via Ly49H (Bubic et al, submitted). Thus,
the m157 mutations are sufficient to explain the escapem157 mutations were detected in nine clones of the
original salivary gland MCMV stock previously passaged virus phenotype of the SCID-MCMV isolates.
in BALB/c mice (data not shown). Although these experi-
ments demonstrated that m157 mutants were selected Discussion
during the course of infection in B6-SCID mice, no con-
clusion could be drawn about whether the mutations Over eons of interacting with their hosts, viruses have
evolved a number of strategies to evade immune re-occurred during the course of infection or represented
the outgrowth of previously existing rare viral subpopu- sponses (Tortorella et al., 2000). Whereas double-
stranded DNA viruses, such as the herpesviruses, havelations in the salivary gland MCMV stock.
To more directly address this question, we repeated developed ORFs that neutralize host immune re-
sponses, virus mutants that escape immunity during thethe experiment with a plaque-purified wt MCMV clone
with a verified normal m157 sequence (Table 3). When course of an infection have been described primarily for
RNA viruses, and in the context of evasion from adaptivetissue culture preparations of this plaque-purified
MCMV clone were used to directly infect B6-SCID mice, not innate immunity (Ciurea et al., 2001; Erickson et al.,
Virus Escape from Innate Immune Control
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Figure 3. Disruption of the Ly49H-m157 Interaction during Infection with SCID-MCMV Isolates
(A) B6-RAG1/ splenocytes were cocultured for 9 hr with noninfected IC-21 cells or IC-21 cells previously infected with wt MCMV, SCID-
MCMV isolate (A1.10), 	m157 (deliberate mutation), or revertant MCMV. The cells were then stained for NK1.1, CD3, and Ly49H and fixed,
permeabilized, and stained for intracellular IFN-. The results shown are gated on NK1.1 CD3 lymphocytes.
(B) Splenic NK cells were harvested from B6 mice infected with 5  104 pfu/mouse of wt MCMV or SCID-MCMV isolates (A1.05, A1.10). The
cells were stained for NK1.1, CD3, and Ly49H. The percentage of NK cells (NK1.1 CD3) that were Ly49H was determined by FACS analysis.
The differences between the % Ly49H NK cells in naive B6 mice (indicated by dashed line) and mice d4 or d5 p.i. with wt MCMV were
statistically significant (p 
 0.05) while the differences between naive mice and mice infected with the SCID-MCMV isolates were not. (Data
represent the average of groups of three to four mice).
(C) Splenic titers at day 3 p.i. in groups of five B6 mice infected with 5  105 pfu/mouse of either tissue-cultured propagated wt or 	m157
(deliberate mutation) MCMV. The differences between the d3 splenic titers in B6 mice infected with wt or 	m157 MCMV were statistically
significant (p  0.00000001).
2001; Goulder et al., 2001; Hunziker et al., 2003; Schrag have dealt with RNA viruses that have significant pro-
pensity towards the development of “quasispecies” dueet al., 1999). Here we report that in the absence of an
adaptive immune response, Ly49H NK cells exert to the inherent infidelity of RNA polymerase (DeFilippis
and Villareal, 2001). Our results demonstrate that similarenough selective pressure to permit the specific out-
growth of MCMV escape mutants with alterations in phenomena may occur during the course of infection
from a single inoculum of a double-stranded DNA virusm157 sufficient to disrupt its interaction with Ly49H on
NK cells and lead to increased splenic titers and mortal- even though DNA viruses are thought to be less prone
to mutations due to higher fidelity of DNA replicationity. To our knowledge, this is the first description of
the in vivo emergence, during the course of a single (DeFilippis and Villareal, 2001). Our initial experiments
revealed the isolation of a number of identical mutantsinfection, of escape mutants of a double-stranded DNA
virus driven by innate immune selective pressure. in different mice that could result from regions in m157
with a higher predisposition to mutation. However, theseMost prior studies of mutant viruses and host defense
Immunity
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Table 1. Mutations in m157 in Splenic SCID-MCMV Isolates from B6-SCID Mice Infected with Salivary Gland-Passaged MCMV
Mouse Frequency Mutation Comment
A1 1/5 305-323 deletion frameshift w/premature stop at 431-433
4/5 961-973 deletion disrupt predicted hydrophobic tail
A2 1/4 G881A premature stop (TAG)
3/4 961-973 deletion disrupt predicted hydrophobic tail
A3 1/2 G881A premature stop (TAG)
1/2 961-973 deletion disrupt predicted hydrophobic tail
B1 1/10 no mutation
1/10 647-648 deletion frameshift w/premature stop at 699-701
2/10 G881A premature stop (TAG)
6/10 961-973 deletion disrupt predicted hydrophobic tail
B2 1/8 no mutation
2/8 G509A gly → asp
1/8 820-918 deletion
1/8 addition of A at 789 premature stop (TAA)
2/8 G881A premature stop (TAG)
1/8 961-973 deletion disrupt predicted hydrophobic tail
B3 1/10 no mutation
5/10 647-648 deletion frameshift w/premature stop at 699-701
4/10 961-973 deletion disrupt predicted hydrophobic tail
C1 1/5 412-414 deletion deletion of Thr
1/5 C485A premature stop (TAA)
1/5 G881A premature stop (TAG)
2/5 961-973 deletion disrupt predicted hydrophobic tail
C2 3/5 G881A premature stop (TAG)
2/5 961-973 deletion disrupt predicted hydrophobic tail
C3 4/5 G881A premature stop (TAG)
1/5 961-973 deletion disrupt predicted hydrophobic tail
C4 5/5 961-973 deletion disrupt predicted hydrophobic tail
C5 1/5 G398T cys → tyr
1/5 G418T asp → tyr
1/5 647-648 deletion frameshift w/premature stop at 699-701
1/5 addition of A at 789 premature stop (TAA)
1/5 G881A premature stop (TAG)
Eleven B6-SCID mice were infected with salivary gland-passaged Smith strain MCMV (2  104 pfu/mouse) in three separate experiments
(denoted by A, B, and C). Homogenates of spleens harvested on day 28 p.i. were used to infect monolayers of NIH-3T12 cells. Five days
later, viral plaques were isolated. From each isolate, viral genomic DNA was harvested, and m157 was PCR amplified for sequencing. Similar
analysis of SCID-MCMV isolates revealed no mutations in m158 (13 isolates) or in m159 (12 isolates) even though the same isolates possessed
m157 mutations (not shown). No m157 mutations were found in 9 wt MCMV clones isolated from the salivary gland stock, previously passaged
in BALB/c mice (not shown).
experiments were conducted with an in vivo passaged viral persistence despite a vigorous immune response
(Cavanaugh et al., 2003). Seeding of the periphery withsalivary gland MCMV preparation, raising the possibility
that the mutants may have been present at low frequen- mutant viruses from the salivary gland may have led to
viremia and NK cell selection in the spleen where thecies in the preparation. When we used a newly cloned
MCMV preparation with an intact m157 sequence, we Ly49H-mediated response is most evident (Scalzo et
al., 1992; Tay and Welsh, 1997).found clustering of distinct m157 mutations in individual
mice, which were different from mutations found in mice The striking increased frequency of mutations in m157
in SCID-MCMV isolates following infection with eitherinfected with the salivary gland inoculum. These results
support the possibility that several of the commonly salivary gland-passaged MCMV or plaque-purified, tis-
sue-cultured MCMV demonstrates that innate immuneidentified mutants in the initial experiments did exist as
rare subpopulations within the salivary gland stock and control by NK cells in the absence of an adaptive im-
mune response resulted in the selective outgrowth ofwere selected during the infection. More importantly, the
data with the tissue culture passaged inoculum strongly viruses that have abnormalities in m157. The increased
frequency of m157 mutations sharply contrasted withsuggest that MCMV is mutating during the course of in-
fection. the absence of mutations found in two other adjacent
m145 family members (m158 and m159) even thoughRegardless of whether the mutant viruses were pre-
existent in the inoculum or developed de novo during all three of these ORFs are dispensable for in vitro viral
propagation (Thale et al., 1995). Detailed analysis of theinfection, it is clear that viruses emerging later during
the course of infection had been selected and did not complete genomic sequence of the SCID-MCMV iso-
lates may reveal additional mutations that potentiallysimply represent re-activation from latency of the origi-
nal virus since the SCID-MCMV isolates had differences contribute to their biological properties. However, the
majority of m157 mutations that were identified wouldin m157 sequence and biological behavior compared to
the original inoculum. Perhaps these mutations oc- prevent expression and retention of m157 on infected
cells, and a deliberate mutation in m157 alone recapitu-curred during ongoing viral replication in an immune
privileged site, such as the salivary gland that manifests lated the phenotype observed with the SCID-MCMV iso-
Virus Escape from Innate Immune Control
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Table 2. Mutations in m157 in Hepatic SCID-MCMV Isolates from B6-SCID Mice Infected with Salivary Gland-Passaged MCMV
Mouse Frequency Mutation Comment
C1 1/5 no mutation
1/5 647-648 deletion frameshift w/premature stop at 699-701
3/5 961-973 deletion disrupt predicted hydrophobic tail
C2 3/5 G881A premature stop (TAG)
2/5 961-973 deletion disrupt predicted hydrophobic tail
C3 1/5 addition of A at 789 premature stop (TAA)
3/5 G881A premature stop (TAG)
1/5 961-973 deletion disrupt predicted hydrophobic tail
C4 1/5 G475T premature stop (TGA)
1/5 G881A premature stop (TAG)
3/5 961-973 deletion disrupt predicted hydrophobic tail
SCID-MCMV isolates were obtained from liver homogenates of four of the five B6-SCID mice in experiment C described in Table 1, and m157
was sequenced.
lates, indicating that the mutations in m157 are sufficient MCMV, and this is confined to two related laboratory
strains. Recent studies have indicated that mutations into account for the increased virulence observed with
the SCID-MCMV isolates. m157 can also be identified in MCMV isolates from wild
mice but the genotype of their hosts with respect toWhy then does MCMV have m157 in the first place,
and why was it not deleted previously? There are several Ly49h was not determined (Voigt et al., 2003). m157
mutations were also identified after sequential salivarypoints worth considering. First, as opposed to many
other viruses, a prominent feature of the herpesvirus life gland passage of K181 strain MCMV in congenic Ly49H
mice, indicating that mutant viruses were resident incycle is the establishment of latency (Knipe et al., 2001);
m157 may play a role in this regard since it provides salivary glands. However, selection of m157 mutants
became evident only after multiple rounds of sequentialthe virus with a mechanism to limit acute host demise.
Perhaps it is advantageous to the virus that the host passage in otherwise immunocompetent mice (Voigt et
al., 2003). Similarly, the studies reported here indicatesurvive to develop a chronic latent infectious state. Over
the lifetime of the infected host, re-activation will lead that mutant viruses were not detectable after a single
inoculum in the presence of adaptive immunity, presum-to low-level infections that can then be spread to many
other acquaintances. By contrast, an acute overwhelm- ably due to effective suppression by CTLs and perhaps
due to other effects of m157 in modulating host immuneing infection provides only a very short period when the
host is well enough to spread the virus. Paradoxically responses. Further analysis is clearly required to ad-
dress these issues.then, immune stimulation by m157 may represent a viral
immune modulating strategy that is beneficial from the Selection pressure by the immune system has been
previously reported to influence the outcome of infec-virus standpoint. Second, m157 may play another role
in immune evasion. Previously, m157 was shown to bind tious challenges. Several examples include the mutation
of antigenic epitopes for virus-specific immunoglobulinan NK cell inhibitory receptor (Ly49I) in the 129 strain
but not C57BL/6 mice (Arase et al., 2002). However, the or TCR (Ciurea et al., 2001; Lopez-Bueno et al., 2003).
However, in almost all cases reported thus far, the vi-relevance of this interaction is unclear due to the limited
expression of Ly49I on only 10% of NK cells in 129 strain ruses escaped adaptive immune control. Here we show
directly that a naturally occurring, mono-specific innatemice. Yet it is possible that m157 may bind a larger
number of NK cell inhibitory receptor-positive cells in immune control mechanism results in readily detectable
viral mutations, indicating that innate immunity is insuffi-other strains or outbred mice, or it may have other im-
mune evasion functions in an analogous manner to a cient for long-term infection control.
In contrast to the plasticity of antigen specificitiesrelated molecule (m152) involved in downregulation of
MHC class I molecules and NKG2D ligands (Krmpotic that are available in unmanipulated adaptive immune
responses, innate immune control mechanisms areet al., 2002; Smith et al., 2002; Tortorella et al., 2000).
Third, there is only limited genomic information on much more limited. Innate immune cells have germline-
Table 3. Mutations in m157 in Splenic SCID-MCMV Isolates from B6-SCID Mice Infected with Plaque-Purified, Tissue-Cultured Propagated
MCMV
Mouse Frequency Mutation Comment
D1 5/7 extra A at 305 frameshift with stop at 315-317 TAA
2/7 G644A TGT  TAT (cys  tyr)
D2 8/8 G538T premature stop (TAA)
D3 1/8 T179G ATT  ATG (ile  met)
7/8 T840A premature stop (TAA)
D4 5/5 deletion of A at 304 premature stop at 311 (TAA)
Smith strain MCMV was plaque-purified from the original salivary gland stock and sequenced to verify that m157 was intact. After only tissue
culture amplification, this MCMV preparation was used to infect four B6-SCID mice (D1 and D2 at 5  104 pfu/mouse and D3 and D4 at 5 
105 pfu/mouse). Individual viral plaques were isolated from splenic homogenates, and m157 was sequenced as described in Table 1.
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plaque-purified wt MCMV (with verified m157 sequence), as indi-encoded receptors, such as Ly49H and those involved
cated.in pattern recognition, such as the Toll-like receptors.
These receptors are often promiscuous in ligand binding
Directed Mutation of m157 in MCMVbut the repertoire is quite limited. There has been no
Directed mutagenesis of the m157 ORF (nt 215898-216884 encoded
evidence thus far for somatic mutations of these recep- on the complementary strand) was performed on the bacterial artifi-
tors to increase their repertoire for a larger panel of cial chromosome (BAC) pSM3fr containing the wt MCMV (Wagner
et al., 1999) following a previously described method (Wagner etligands or to deal with mutating pathogens. Thus, more
al., 2002). The BAC-derived MCMV is a Smith strain MCMV withdetailed analysis of infectious challenges may reveal
genes 151 to 158 derived from the K181 MCMV strain. However,mutations of viruses or micro-organisms that escape
m157 was confirmed to be identical in sequence in both Smith andthese receptors of innate immunity, but given the multi-
K181 strains. Mutagenesis of m157 was performed by deletion of
layered immune control normally suppressing the out- nucleotides 216291-216884 (	m157) via homologous recombination
growth of escape mutants, these mutations may be evi- in E. coli. A revertant virus was generated by inserting the m157
ORF and its native promoter ectopically between ORF m16 and m17dent primarily when other arms of the immune system
(between nt 15678 and 15759). A more complete description of theare disabled.
generation and characterization of 	m157 has been submitted asTaken in a broader context, therefore, our findings
a separate manuscript (I.B. et al., unpublished data).have significant implications in the clinical setting. In
immunodeficient humans, such as AIDS or immunosup- Plaque Assays
pressed organ transplant patients, the absence of com- Viral titers were determined by standard plaque assay (Brown et al.,
petent adaptive immunity is associated with the devel- 2001). In brief, organs from infected mice on day 3 p.i. were weighed
and frozen in 1 ml aliquots of D10 media (DMEM (Gibco) with 10%opment of severe viral illnesses, such as CMV viremia,
calf serum (Hyclone), 100 U/ml penicillin, 100 g/ml streptomycin,meningitis, pneumonia, and retinitis, similar to the wide-
and 2 mM glutamine). Spleens or livers were thawed and homoge-spread disease in our infected SCID and RAG/ mice
nized with Dounce homogenizers on ice. Serial dilutions of the
(Fauci and Lane, 2001; Fishman and Rubin, 1998). Se- spleen or liver lysates were then used to infect monolayers of per-
vere or recurrent viral infections have also been reported missive NIH-3T12 fibroblasts in triplicate on six-well plates. After a
in patients with selective genetic defects in adaptive 1 hr incubation period, the cells were overlaid with overlay media
(D5 media with 1% HEPES and 0.5% noble agar [Difco]). On day 3,immunity but with intact functional NK cell populations,
the cells were again overlaid with overlay media. Titers were readsuch as severe combined immunodeficiency patients
in triplicate by two independent observers on day 4 using a lightwith defects in RAG1/2 (T- NK SCID) (Schwarz et al.,
microscope with 4magnification. Titers are presented as Log (pfu/
1999). Interestingly, in immunosuppressed transplant 100 mg spleen) or Log (pfu/1 gm liver).
patients, CMV disease typically occurs relatively late
(more than a month), rather than acutely, after lung Propagation of Mutant Virus
transplants from CMVdonors, a time course again rem- Individual viral plaques were isolated from monolayers of NIH-3T12
cells 5 days after inoculation with spleen or liver homogenates ofiniscent of our studies (Fishman and Rubin, 1998). Fur-
B6-SCID mice harvested at day 28 p.i. The viral plaques were resus-thermore, in uncontrolled infections in immunocom-
pended in 0.5 ml of media and expanded by in vitro propagation inpromised patients, the nature of the viruses has not
monolayers of NIH-3T12 in six-well plates. After m157 sequencing,
been fully characterized. Here we show that mutated nine of these mutant strains of virus (seven with the same thirteen
forms and not the original virus emerge during the nucleotide 3’ deletion, one with a 5’ deletion, and one with a point
course of infection. We therefore predict that certain mutation from the experiment with plaque-purified MCMV in Table
3) were propagated in MCMV-sensitive BALB/c mice to prepareviral infections in immunodeficient patients may be due
salivary gland preparations for in vivo experiments. In addition, tis-to viruses escaping innate immunity and that genomic
sue culture propagated preparations were generated for some ex-analysis of such clinical isolates may provide valuable
periments, as indicated.
clues to the viral products that interact with various
components of the host innate immune system. Viral Genetic Analysis
MCMV genomic DNA was extracted using QIAmp DNA Blood mini-
kits (Qiagen) and quantified with a spectrophotometer. MCMV ORFsExperimental Procedures
were PCR amplified using TAQ polymerase (Promega) with the fol-
lowing primers (10 pmol/reaction) CTT GTT AGT GCC GGT GTCMice
TGT and CAT GGT ACA CAA ACG CAG A (m157), TGA CCA TGTC57BL/6 (B6), C57BL/6-SCID (B6-SCID), and C57BL/6-RAG1/
CAA GAG GTA CTG and TCT CAT CGA GTC GTG TGC CG (m158),(B6-RAG) mice were obtained from the Jackson Laboratory (Bar
and GAA AAT ATA GTT AGC ACC GTT AG and CGC TTC TAT ACAHarbor, ME). Mice were maintained under specific pathogen-free
GAT AAG GGC (m159). PCR products were purified with QIAquickconditions and used between 8–14 weeks of age. All experiments
PCR purification kits (Qiagen). Sequencing reactions were preparedwere conducted in accordance with institutional guidelines for ani-
using ABI Big Dye Terminators v 2.0 or v 3.1 following standard ABImal care and use.
protocols. Sequencing was performed on a 377 DNA Sequencer
(ABI Prism) as well as by the core sequencing facility at Washing-
ton University.Virus and Infection of Mice
Smith strain MCMV was a generous gift of H. Virgin (Washington
University, St Louis, MO). A salivary gland stock of MCMV was Splenocyte Preparation, Intracellular Staining,
and Flow Cytometryprepared from BALB/c mice that had been intraperitoneally (i.p.)
injected with 1  106 pfu tissue-culture propagated MCMV, and the Four or five days after infection, mice were euthanized and single-
cell suspensions of splenocytes were prepared using standard tech-titer was determined via standard plaque assay using permissive
NIH 3T12 fibroblasts (American Type Culture Collection, ATCC, Man- niques (Dokun et al., 2001). The splenocytes were stained with
PerCP-145-2C11 (CD3, Pharmingen), APC-PK136 (NK1.1, Phar-assas, VA) (Brown et al., 2001). For in vivo experiments, mice were
injected i.p. with 2  104 to 1  105 pfu/mouse from a salivary gland mingen), PE-streptavidin (Pharmingen), biotinylated-3D10 (Ly49H,
Smith et al., 2000), or biotinylated-4E4 (Ly49D, Idris et al., 1999). ToMCMV stock with a titer of 5  106 pfu/ml. Alternatively, some
experiments were performed with tissue-culture propagated, block nonspecific binding of antibodies to Fc receptors, all antibod-
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ies were diluted in presence of mAb 2.4G2 (Fc II/III receptor, ATCC). DeFilippis, V.R., and Villareal, L.P. (2001). Virus evolution. In Fields
Virology, D.M. Knipe and P.M. Howley, eds. (Philadelphia: LippincottAn in vitro assay to detect preferential IFN- production was per-
formed as previously described (Smith et al., 2002). In brief, Williams & Wilkins), pp. 353–370.
C57BL/6-RAG1/ splenocytes were cocultured for 9 hr with unin- Dokun, A.O., Kim, S., Smith, H.R., Kang, H.S., Chu, D.T., and Yoko-
fected IC-21 cells (ATCC) or IC-21 cells previously infected with yama, W.M. (2001). Specific and nonspecific NK cell activation dur-
either tissue-culture propagated wt MCMV or mutant MCMV at an ing virus infection. Nat. Immunol. 2, 951–956.
MOI of 5 for 24 hr. Brefeldin A (BD Pharmingen) was added for the
Erickson, A.L., Kimura, Y., Igarashi, S., Eichelberger, J., Houghton,
last 8 hr of the coincubation. Cells were fixed and permeabilized
M., Sidney, J., McKinney, D., Sette, A., Hughes, A.L., and Walker,
using Cytofix/Cytoperm kit (BD Pharmingen) and then stained with
C.M. (2001). The outcome of hepatitis C virus infection is predicted
FITC-XMG1.2 (IFN-, Pharmingen). Cells were analyazed using a
by escape mutations in epitopes targeted by cytotoxic T lympho-
FACSCalibur cytometer (BD Biosciences) gating on the NK1.1
cytes. Immunity 15, 883–895.
CD3 populations.
Farrell, H.E., Vally, H., Lynch, D.M., Fleming, P., Shellam, G.R.,
Scalzo, A.A., and Davis-Poynter, N.J. (1997). Inhibition of naturalStatistical Analysis
killer cells by a cytomegalovirus MHC class I homologue in vivo.Heteroscedastic two-tailed student t-test was used to determine
Nature 386, 510–514.statistically significant differences (p 
 0.05).
Fauci, A.S., and Lane, H.C. (2001). Human immunodeficiency virus
(HIV) disease: AIDS and related disorders. In Harrison’s PrinciplesSurvival Curves
of Internal Medicine, E. Braunwald, A.S. Fauci, D.L. Kasper, S.L.Mice were injected i.p. with wt MCMV or MCMV-SCID isolates at
Hauser, D.L. Longo, and J.L. Jameson, eds. (New York: McGraw-the indicated dosages and observed daily for 28 days. Moribund
Hill), pp. 1852–1913.mice were euthanized per institutional guidelines.
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